课题基金 / 基金详情

Dissecting the signals that maintain HIV-specific CD8+ T cell exhaustion

Dissecting the signals that maintain HIV-specific CD8+ T cell exhaustion
剖析维持 HIV 特异性 CD8 T 细胞耗竭的信号
批准号:
10330433
负责人:
Rachel Lena Rutishauser
金额:
$20.84万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-02-06 至 2023-01-31
关键词:
AffectAnimal ModelAnimalsAntigensAreaAwardBlood CellsBlood specimenCD8-Positive T-LymphocytesCaliforniaCell Differentiation processCell physiologyCellsCellular biologyChronicClinicalClinical ResearchCommunicable DiseasesDataDevelopmentDiseaseDisease remissionDoctor of PhilosophyEffector CellEnvironmentFlow CytometryFundingGatekeepingGenetic TranscriptionGoalsHIVHIV InfectionsHumanImmune responseImmunityImmunologicsImmunologistImmunologyIndividualInfectionInfection ControlInflammationInflammatoryInterleukin-1 betaInterventionLaboratoriesLymphoid TissueMHC Class I GenesMalignant NeoplasmsMeasuresMediatingMemoryMentored Patient-Oriented Research Career Development AwardMentorsMonoclonal AntibodiesMusPD-1 blockadePathogenesisPersonsPhenotypePlacebosPopulationPositioning AttributeProliferatingRegenerative capacityRegulationResearchResearch PersonnelResearch PrioritySan FranciscoSchoolsScientistSignal TransductionSpecialistT cell differentiationT cell therapyT memory cellTherapeutic InterventionTissuesToxic effectTrainingTranslational ResearchUnited States National Institutes of HealthUniversitiesVaccinationVaccine DesignVaccine TherapyVaccinesVirusWNT Signaling Pathwayacute infectionantiretroviral therapybasecareerchronic infectioncohortcytokineeffective therapyexhaustexhaustionimmune activationimmunomodulatory therapiesinhibitorinsightlymph nodesnovel strategiesnovel therapeuticsnovel vaccinespatient oriented researchperipheral bloodpost interventionprogramsrecruitregeneration functionregeneration potentialresponsesingle-cell RNA sequencingskillstherapeutic developmenttranscription factortranscriptometranscriptomicstranslational scientist

项目摘要

项目成果

Rachel Lena Rutishauser的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 这是雷切尔·鲁蒂肖瑟博士的K23奖项申请书,她是一名传染病研究员,医学博士,博士 加州大学旧金山分校正在确立自己作为一名年轻研究员的地位-- 艾滋病毒免疫学的定向研究。她的目标是将她的博士研究生背景应用于基础CD8+ T细胞生物学研究HIV保护性免疫反应和功能障碍免疫反应的机制 感染。全球近4000万人感染艾滋病毒并确定诱发艾滋病毒的干预措施 缓解或治愈是美国国立卫生研究院高度重视的研究领域。许多方法建议通过引出 保护HIV特异性CD8+T细胞。然而,为了有效,这些疗法需要克服艾滋病毒-- 特异性CD8+T细胞耗竭。衰竭的定义是抗原再生能力的丧失- 特异性CD8+T细胞增殖并产生功能性效应细胞。这一K23奖项将为Dr。 Rutishauser支持探索HIV特异性CD8+T细胞耗尽是如何由以下因素调节的:(1)记忆 CD8+T细胞相关的转录程序,(2)组织微环境,(3)慢性炎症。 具体地说,她将对HIV特异性进行表型、功能和单细胞转录分析 30例HIV感染者外周血、淋巴结和肠道组织中的MHC-I类四聚体+CD8+T细胞 她将从加州大学旧金山分校的SCOPE队列中招募来自三个临床小组的感染者: 自然控制感染的个人(控制者),以及非控制者开启和关闭抗逆转录病毒 治疗(ART)。她还将确定减少慢性炎症是否可以增强HIV特异性CD8+T细胞 通过利用NIH资助的一项正在进行的临床研究(NCT02272946)的外周血液样本来发挥作用 接受IL-1β抑制剂Canakinumab的抗逆转录病毒治疗的艾滋病毒感染者。要实现 这些目标,Rutishauser博士将由HIV翻译免疫学家Peter Hunt博士共同指导, 艾滋病毒免疫激活机制专家、实验室科学家约瑟夫·迈克·麦克库恩博士 世卫组织在艾滋病毒发病机制方面取得了几项基础性发现,史蒂文·迪克斯博士是该领域的领导者 艾滋病毒治疗领域,以及在T细胞分化方面有专长的免疫学家马克·安塞尔博士。通过专注于 指导培训和课程工作计划,候选人将在临床研究方面发展高级技能, 人类翻译免疫学和单细胞转录分析。这些研究的结果是 预计将与艾滋病毒治愈研究直接相关,并广泛适用于开发其他疾病的治疗方法 出现耗尽抗原特异性CD8+T细胞的疾病状态,如其他慢性感染和 癌症。最终,这里概述的培训和研究计划将在Rutishauser博士过渡期间为她提供支持 从基础免疫学家和临床传染病专家到翻译研究人员 具备追求独立职业的技能,专注于阐明以下基本原则 CD8+T细胞生物学,并为传染病的治疗和疫苗的发展提供信息。
英文摘要
Project Summary This is an application for a K23 award for Dr. Rachel Rutishauser, MD, PhD, a fellow in Infectious Diseases at the University of California, San Francisco who is establishing herself as a young investigator in patient- oriented studies of HIV immunology. Her goal is to apply her PhD graduate school background in basic CD8+ T cell biology to study the mechanisms that underlie protective and dysfunctional immune responses in HIV infection. Nearly forty million people worldwide are infected with HIV and identifying interventions to induce HIV remission or cure is an NIH high priority research area. Many approaches propose to do so by eliciting protective HIV-specific CD8+ T cells. However, in order to be effective, these therapies need to overcome HIV- specific CD8+ T cell exhaustion. Exhaustion is defined as a loss in the regenerative capacity of antigen- specific CD8+ T cells to proliferate and generate functional effector cells. This K23 award will provide Dr. Rutishauser with the support to explore how HIV-specific CD8+ T cell exhaustion is regulated by: (1) memory CD8+ T cell-associated transcriptional programs, (2) tissue microenvironments, and (3) chronic inflammation. Specifically, she will perform phenotypic, functional, and single-cell transcriptomic analysis of HIV-specific MHC Class I tetramer+ CD8+ T cells from the peripheral blood, lymph node, and gut tissue of thirty HIV- infected individuals who she will recruit from the UCSF-based SCOPE cohort from three clinical groups: individuals who naturally control infection (controllers), as well as non-controllers on and off of antiretroviral therapy (ART). She will also determine if reducing chronic inflammation can enhance HIV-specific CD8+ T cell function by leveraging peripheral blood samples from an ongoing NIH-funded clinical study (NCT02272946) of ART-suppressed HIV-infected individuals who are administered the IL-1β inhibitor, canakinumab. To achieve these goals, Dr. Rutishauser will be co-mentored by Dr. Peter Hunt, an HIV translational immunologist and expert in the mechanisms of HIV immune activation, Dr. Joseph Mike McCune, a laboratory-based scientist who has made several fundamental discoveries about HIV pathogenesis, Dr. Steven Deeks, a leader in the HIV cure field, and Dr. Mark Ansel, an immunologist with expertise in T cell differentiation. Through a focused program of mentored training and coursework, the candidate will develop advanced skills in clinical research, human translational immunology, and single-cell transcriptional analysis. The results of these studies are anticipated to be directly relevant to HIV cure research and widely applicable to developing treatments for other disease states in which exhausted antigen-specific CD8+ T cells arise, such as other chronic infections and cancer. Ultimately, the training and research plans outlined here will support Dr. Rutishauser as she transitions from being a basic immunologist and clinical infectious disease specialist to being a translational researcher equipped with the skills to pursue an independent career focused on elucidating the fundamental principles of CD8+ T cell biology and informing the development of therapeutics and vaccines for infectious diseases.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection.
SARS-CoV-2 感染急性期后血浆抗原的持续存在。
DOI: 10.1101/2023.10.24.23297114
发表时间: 2023
期刊: medRxiv : the preprint server for health sciences
影响因子: --
作者: [Peluso,MichaelJ, Swank,ZoeN, Goldberg,SarahA, Lu,Scott, Dalhuisen,Thomas, Borberg,Ella, Senussi,Yasmeen, Luna,MichaelA, Song,CelinaChang, Clark,Alexus, Zamora,Andhy, Lew,Megan, Viswanathan,Badri, Huang,Beatrice, Anglin,Khamal, Hoh,Reb]
通讯作者: Hoh,Reb
DOI: 10.1097/coh.0000000000000748
发表时间: 2022-09-01
期刊: CURRENT OPINION IN HIV AND AIDS
影响因子: 4.1
作者: [Rutishauser, Rachel L., Trautmann, Lydie]
通讯作者: Trautmann, Lydie
Targeting HIV-specific T cell differentiation programs to enhance post-treatment control of HIV
Targeting HIV-specific T cell differentiation programs to enhance post-treatment control of HIV
Dissecting the signals that maintain HIV-specific CD8+ T cell exhaustion - administrative supplement
海外基金